key: cord-0715256-lyw249rt
authors: Kow, Chia S.; Ramachandram, Dinesh S.; Hasan, Syed S.
title: The effectiveness of mRNA‐1273 vaccine against COVID‐19 caused by Delta variant: A systematic review and meta‐analysis
date: 2022-01-18
journal: J Med Virol
DOI: 10.1002/jmv.27568
sha: 29586977c43705f184b15babcbc08e7ad47bf1c3
doc_id: 715256
cord_uid: lyw249rt

We aimed to perform meta‐analyses to summarize the overall effectiveness of the mRNA‐1273 vaccine against COVID‐19 caused by the Delta variant from real‐world studies. A systematic literature search with no language restriction was performed in electronic databases to identify eligible observational studies that reported the effectiveness of the mRNA‐1273 vaccine to prevent reverse transcription‐polymerase chain reaction (RT‐PCR) confirmed COVID‐19 caused by Delta variant of SARS‐CoV‐2 (B.1.617.2). A random‐effects meta‐analysis model was used to estimate the pooled odds ratio (OR) at a 95% confidence interval (CI), and the vaccine effectiveness was indicated as (pooled OR − 1)/OR. Five studies were included for this systematic review and meta‐analysis. The meta‐analysis revealed that the administration of mRNA‐1273 vaccine protected against RT‐PCR confirmed COVID‐19 caused by Delta variant ≥21 days post first dose, with pooled vaccine effectiveness of 66% (95% CI: 65%–67%), as well as ≥14 days after the second dose, with pooled vaccine effectiveness of 91% (95% CI: 84%–95%). In conclusion, the mRNA‐1273 vaccine offers a substantial protection rate against RT‐PCR confirmed COVID‐19 caused by the Delta variant upon full vaccination, although with slightly reduced effectiveness relative to other strains of SARS‐CoV‐2.

A random-effects model was used to estimate the pooled odds ratio (OR) for the occurrence of COVID-19 caused by Delta variants between vaccinated and unvaccinated individuals at 95% confidence intervals (CIs).

We examined the heterogeneity between studies using the I 2 statistics and the χ 2 test, with 50% and p < 0.10, respectively, were considered as an indication of the presence of heterogeneity. The vaccine effectiveness was indicated as (pooled OR − 1)/OR, together with a 95% CI. All analyses were performed using Meta XL, version 5.3 (EpiGear International).

Our literature search yielded 4441 records. After deduplication and application of eligibility criteria, 14 relevant articles were shortlisted for inclusion through full-text examination. Of these, nine studies Figure 1) . Eventually, five studies were included in this systematic review and meta-analysis; all included studies were of retrospective case-control design. [4] [5] [6] [7] [8] The study characteristics are depicted in Table 1 . The included studies are deemed moderate-tohigh quality with a Newcastle-Ottawa Scale of 8 ( Table 1) .

The meta-analysis of three studies 4-6 revealed significant pro- In conclusion, the mRNA-1273 vaccine offers a substantial protection rate against RT-PCR confirmed COVID-19 caused by the Delta variant upon full vaccination. Therefore, measures should be taken to hasten the global vaccination efforts, preferably with mRNA vaccines, to curb COVID-19 transmission, which may drive the future emergence of variants of concern.

The authors declare that there are no conflict of interests.

The authors confirm that the data supporting the findings of this study are available within the article. 

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap

The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses

Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and severe COVID-19 in the UK. medRxiv

Effectiveness of COVID-19 vaccines against variants of concern in Ontario

Comparative single-dose mRNA and ChAdOx1 vaccine effectiveness against SARS-CoV-2, including early variants of concern: a test-negative design

BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the Delta variant in Qatar

Effectiveness of mRNA-1273 against Delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study

Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase

The effectiveness of mRNA-1273 vaccine against COVID-19

caused by Delta variant: A systematic review and meta-analysis